IDEXX Laboratories, Inc.
IDXX Healthcare Diagnostics & Research
IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.66%, EPS grew 17.2%, free cash flow grew 111.4% and total debt fell 14.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three.
Follow IDXX
IDEXX Laboratories, Inc. (IDXX) Free cash flow margin
IDEXX Laboratories, Inc.'s free cash flow margin over the twelve months to 30 June 2026 was 27.2%, up 2.9 percentage points from fiscal 2025 (24.3%). Over the past ten years it has ranged from 8.67% (fiscal 2015) to 24.3% (fiscal 2025) — the current reading is the highest in ten years. That is above the Diagnostics & Research industry median of 0.00% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Embed this chart
Annual newest first
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2025 | 24.3% | 3.77 |
| FY2024 | 20.5% | (0.63) |
| FY2023 | 21.1% | 9.70 |
| FY2022 | 11.4% | (8.37) |
| FY2021 | 19.8% | (0.19) |
| FY2020 | 20.0% | 7.34 |
| FY2019 | 12.6% | 0.11 |
| FY2018 | 12.5% | (2.54) |
| FY2017 | 15.1% | (0.38) |
| FY2016 | 15.4% | 6.77 |
Against its own ten years
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| IDXX IDEXX Laboratories, Inc. | 27.2% |
| MTD Mettler-Toledo International, Inc. compare | 20.9% |
| ILMN Illumina, Inc. compare | 20.7% |
| A Agilent Technologies, Inc. compare | 17.2% |
| IQV IQVIA Holdings Inc. compare | 13.3% |
| DGX Quest Diagnostics Incorporated compare | 11.7% |
| LH Labcorp Holdings Inc. compare | 8.16% |
| WAT Waters Corporation compare | 7.89% |
| NTRA Natera, Inc. compare | 3.11% |
| Diagnostics & Research industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on IDXX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement